The Banking and Strategy Initiative

Chillin' out till it needs to be funded

Category Archives: Healthcare

Global Mid Day Report: Natural Gas Inventories scare investors, Hospitals provide the only cheer

The Euro tumbled closer to breaking down below 1.24 levels today afternoon as the Natural Gas Report in the US shored up inventories of 3000 BCF by another 57 BCF … Continue reading

June 28, 2012

US Economy: ICSC sales put on brakes, Case Schiller worst since 2006, Health back with a GOP agenda?

Though the Fed would have preferred being proved right ont he continuing recoevery its indicated fears are coming true though no Jobs number is due this Tuesday. The Weekly Goldman … Continue reading

March 27, 2012

Pfizer in advanced stages to sell off animal health and infant nutrition businesses | Deal Insight

Pfizer’s Animal health business has a 19% share of market and is so profitable that industry leader Bayer would have purchased it at a tad lower than $19 bln. However … Continue reading

February 19, 2012

Healthcare's big week! Biotech gets in with two | Deal insight

Biotechnology firms locally on hand in the USA worked out quick deals in the drug development firms for leukemia and lymphoma with equity premiums likely still underbidding the valueof niche … Continue reading

January 26, 2012

Bristol Myers offers $2.5 bln for Inhibitex | Advantage Dealbook

This next Pharma deal happened in the first week of January 2012 itself as another maker of Hepatitis C drugs in Georgia recommended Bristol Myers’ $26 per share offer to … Continue reading

January 9, 2012

Crisis Theater: Greece makes it, US battles with debt deal

Including the McConnell plan asking for four instalments of debt ceiling increase, the US now has 3 public options or more depending on who you are listening to, thus implying … Continue reading

July 22, 2011 · 3 Comments

The Big Pharma rebuilding "decade": Is Big Pharma ready for the competition?

Well frankly, after our efforts to read up and check the air pressure on the Big Pharma machines, we find the restructuring effort in each case expensive and not worth … Continue reading

April 19, 2011 · 2 Comments

After Pfizer and Merck, J&J gets up to go | Advantage Dealbook

J&J has seen better days especially with brand rebuilding taking up the better part of 2010 and Pfizer and Glaxo running away with the honors with a Genzyme bid and … Continue reading

April 17, 2011 · 1 Comment

Of FDI and Another Sovereign Wealth Fund weekend |, Advantage 'zyaada'

A primer on Sovereign Wealth Funds and their appetite for International Investment You have already heard this a couple of times in the bull pen before the trading day begins … Continue reading

June 1, 2010 · 6 Comments

it's the Democrats , stupid!

Wall Street vs Main Street Even as Apple, J&J and Goldman Sachs itself came out with sterling earnings after IBM’s poor draw yesterday, Markets were shcked into a stupor by … Continue reading

April 21, 2010